Hormone and gut bacteria changes after endoscopic sleeve gastroplasty
Part of Hormones & metabolism clinical trials.
This study looks at how a procedure called endoscopic sleeve gastroplasty (a way to reduce stomach size without surgery) affects hormones and gut bacteria. It may help people with obesity lose weight and improve related health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your body mass index (BMI) is between 30 and 40.
- You have been approved for endoscopic sleeve gastroplasty or sleeve gastrectomy by your medical team.
- You are not currently taking weight-loss medications like GLP-1 analogs.
- You have not had prior stomach surgery or certain stomach conditions.
- You are not pregnant or breastfeeding, and you can undergo general anesthesia and CT scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at factors that predict weight loss success after a non-surgical stomach reduction procedure (endoscopic sleeve gastroplasty). It may help if you have obesity-related health problems and have not succeeded with diet or lifestyle changes.
This trial tests a procedure called Endoscopic Sleeve Gastroplasty (ESG) as a non-surgical option for weight loss. It aims to help people who have not been able to lose weight with diet and exercise, and who either cannot or prefer not to have bariatric surgery.
This study tracks people with obesity who get an endoscopic sleeve gastrectomy, a procedure that reduces stomach size without surgery. The goal is to see how safe and effective it is in everyday practice.
This study tests a weight-loss procedure called endoscopic sleeve gastroplasty (a stomach-reducing procedure done through a scope) in people with both obesity and inflammatory bowel disease (IBD). It aims to see if the procedure is safe and helpful for this group.
This study tests a procedure called endoscopic sleeve gastroplasty, which uses a device to reduce the size of your stomach without surgery. It aims to see if this helps improve blood sugar control and weight in adults with type 2 diabetes and obesity.
This study compares two similar minimally invasive procedures to help with weight loss. The goal is to see which technique is safer and more effective for people with a high body mass index (BMI).
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.